Pregled bibliografske jedinice broj: 550367
Regulation of p53 by Ribosomal Stress
Regulation of p53 by Ribosomal Stress // Advances in Immunology and Cancer Biology
Istanbul, Turska, 2011. (pozvano predavanje, nije recenziran, neobjavljeni rad, znanstveni)
CROSBI ID: 550367 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Regulation of p53 by Ribosomal Stress
Autori
Volarević, Siniša
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, neobjavljeni rad, znanstveni
Skup
Advances in Immunology and Cancer Biology
Mjesto i datum
Istanbul, Turska, 15.04.2011. - 17.04.2011
Vrsta sudjelovanja
Pozvano predavanje
Vrsta recenzije
Nije recenziran
Ključne riječi
p53; ribosomal stress
Sažetak
The capacity of p53 protein to detect many cancer-related stresses and appropriately respond by regulating target genes that induce various biological responses is essential for prevention of malignancies in humans. Currently, it is not known how such diversity of stress signals can be integrated by a single molecule. A few years ago we reported an observation that genetic disruption of ribosome biogenesis by conditional deletion of one allele of ribosomal protein S6 gene elicits a p53-dependent checkpoint response. Based on the available literature other researchers proposed that most p53-inducing stresses compromise ribosome biogenesis and nucleolar structure. Furthermore, RPL5, RPL11, RPL23, RPL26 and RPS7 have been suggested as transducers of p53-activating signals in response to pharmacologic inhibition of ribosome biogenesis. We have recently shown that a number ribosomal and non-ribosomal cellular stresses utilize RPL5, RPL11 but not RPL23, RPL26 and RPS7 to activate the p53 tumor suppressor. Given the essential role of RPL5 and RPL11 in p53 activation after exposure of cells to various stressors, we hypothesized that mutations in these genes could arise in human colon cancers, granting an advantage to cells in escaping p53 tumor suppression. By genomic sequencing of DNA from colon cancer samples we identified a few cancer-associated heterozygous mutations in the coding regions of RPL11 and RPL5. We are planning to test the possibility that RPL5 and RPL11 are bona fide tumor suppressors in the near future
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
062-1081347-0370 - Odgovor stanica sisavaca na pogrešku u sintezi ribozoma in vivo (Volarević, Siniša, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Rijeka
Profili:
Siniša Volarević
(autor)